Annelise Bache
Retired at Novo Nordisk | Asnæs, Region Zealand, Denmark
Annelise Bache’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
QA Manager Diabetes Finished Products, Kalundborg at Novo Nordisk in July 1998 - July 2026
Retired at Novo Nordisk in June 2024 - Present
QA Principal Scientist at Novo Nordisk in November 2000 - June 2024
QA Principal Scientist, Diabetes API at Novo Nordisk A/S, Diabetes API in July 2026 - June 2024
QA kemiker at Novo Nordisk in August 1996 - July 1998
Danmarks Farmaceutiske Universitet, July 1979 to July 1987
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Discover more about Novo Nordisk
Global Director Frontline Excellence Rare Diseases, Novo Nordisk
Owner at Veum Consulting
(March 2015 – Present)
PMP® | Regulatory Affairs Project Lead (Business Area Middle East, Affrica & CIS) at Novo Nordisk
Regulatory Affairs Project Lead (Business Area Middle East, Africa &CIS) at Novo Nordisk
(January 2024 – Present)
Medical Science Liaison, Diabetes & Renal
Wine Rep at ONEHOPE Wine
(June 2021 – Present)
Public Affairs Manager presso Novo Nordisk
Public Affairs Manager at Novo Nordisk
(May 2022 – Present)
Obesity Market Access | Novo Nordisk Canada
Consultant at Global Market Access Solutions
(May 2026 – May 2026)
Associate Director – Novo Nordisk
Student in Business Partner Operation Nordic (BPO) at IBM
(January 2006 – May 2026)
What is Anne-lise Bache email address?
Email Anne-lise Bache at [email protected]. This email is the most updated Anne-lise Bache's email found in 2026.
How to contact Anne-lise Bache?
To contact Anne-lise Bache send an email to [email protected]. (updated on April 24, 2026)
What company does Annelise Bache work for?
Annelise Bache works for Novo Nordisk.
What is Annelise Bache's role at Novo Nordisk?
Annelise Bache is Retired
What industry does Annelise Bache work in?
Annelise Bache works in the Pharmaceuticals industry.
